共 29 条
- [21] How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S474 - S474
- [27] Variations in person to person's DNA can have a big effect on genes that control how an individual respond to different glucose lowering therapies - a role in personalized pharmacogenomics? DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 909 - 909
- [29] STUDIES ON EXPERIMENTAL IMMUNE-COMPLEX NEPHRITIS .3. THERAPEUTIC EFFECT OF PROSTAGLANDIN-E1 ALPHA-CYCLODEXTRIN HOST MOLECULE (PGE1.CD) ON SERUM SICKNESS NEPHRITIS IN RATS JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (04): : 407 - 414